Bausch Health Companies (BHC) EBITDA Margin (2009 - 2026)
Bausch Health Companies (BHC) reported EBITDA Margin of 36.54% for Q2 2026, up 5.23 percentage points from 31.30% a year earlier and up 61.93 percentage points from the prior quarter.
Bausch Health Companies (BHC) EBITDA Margin (2009 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Bausch Health Companies' EBITDA Margin came in at 19.61%, down 10.01 percentage points year-over-year; for FY2025, it came in at 30.34%, up 0.55 percentage points from FY2024.
- EBITDA Margin has increased for three consecutive years, though with a five-year change of -1.57 percentage points (FY2020 to FY2025).
- By year, EBITDA Margin came in at 29.80% in FY2024 (+3.62 pp), 26.17% in FY2023 (+2.21 pp), 23.97% in FY2022 (-0.42 pp) and 24.39% in FY2021 (-7.53 pp).
- The Q2 2026 figure ranks as the highest quarterly EBITDA Margin since Q3 2021.
- Year over year, EBITDA Margin gained in five of the last eight quarters, with an average year-over-year change of -3.60 percentage points.
- The high point for year-over-year EBITDA Margin in five years was Q1 2022 (a gain of 24.32 percentage points); the low point was Q1 2026 (a drop of 51.78 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at -25.40% (Q1 2026), 28.11% (Q4 2025) and 35.10% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,261.99 Bn | 1,235.61 Bn | 20.46 Bn | 54.65% |
| 2 | Johnson & Johnson | 678.93 Bn | 598.79 Bn | 17.30 Bn | 32.68% |
| 3 | AbbVie | 518.29 Bn | 486.30 Bn | 13.12 Bn | 46.88% |
| 4 | Merck | 365.98 Bn | 328.92 Bn | 13.19 Bn | 40.75% |
| 5 | Novartis Ag | 316.85 Bn | 290.09 Bn | - | - |
| 6 | Astrazeneca | 293.40 Bn | 267.29 Bn | 13.26 Bn | 39.77% |
| 7 | Amgen | 251.78 Bn | 203.43 Bn | 7.58 Bn | 46.62% |
| 8 | Gilead Sciences | 210.61 Bn | 185.71 Bn | 6.73 Bn | 50.63% |
| 9 | Pfizer | 166.87 Bn | 114.23 Bn | 12.56 Bn | 42.49% |
| 10 | Bausch Health Companies | 3.16 Bn | -3.76 Bn | 2.21 Bn | 43.45% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 43.45% |
| Jun 30, 2026 | 36.54% |
| Mar 31, 2026 | -25.40% |
| Dec 31, 2025 | 28.11% |
| Sep 30, 2025 | 35.10% |
| Jun 30, 2025 | 31.30% |
| Mar 31, 2025 | 26.38% |
| Dec 31, 2024 | 34.35% |
| Sep 30, 2024 | 26.02% |
| Jun 30, 2024 | 30.00% |
| Mar 31, 2024 | 28.56% |
| Dec 31, 2023 | 29.28% |
| Sep 30, 2023 | 15.33% |
| Jun 30, 2023 | 34.10% |
| Mar 31, 2023 | 25.98% |
| Dec 31, 2022 | 6.25% |
| Sep 30, 2022 | 29.37% |
| Jun 30, 2022 | 28.37% |
| Mar 31, 2022 | 33.94% |
| Dec 31, 2021 | 33.83% |
Bausch Health Companies EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BHC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BHC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BHC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();